| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |